Mast 01
Mast 02
Mast 03
Mast 04
Mast 05
Mast 06
Mast 07
Mast 08

Cool Classics Cool 102

Listen Live!

No Content

  • Legalizing pot has not spurred use among U.S. teens: study

    Marijuana plants for sale are displayed at the medical marijuana farmers market in Los AngelesBy Moriah Costa WASHINGTON (Reuters) - A rise in marijuana use among U.S. teens over the past 20 years has no significant tie to the legalization of marijuana for medical use in many states, according to a new research paper. Comparing surveys of marijuana use by adolescents conducted annually by the federal Centers for Disease Control and Prevention, researchers found the probability that a high schooler had used pot in the last 30 days was no more than 0.8 percent higher in legal states compared to states that had not approved medical marijuana. "Our results are not consistent with the hypothesis that the legalization of medical marijuana caused an increase in the use of marijuana among high school students," D. Mark Anderson of Montana State University, Daniel Rees of the University of Colorado and Benjamin Hansen of the University of Oregon wrote.

  • NCAA agrees to settle head injury suit for $70 million

    CHICAGO (Reuters) - The NCAA has agreed to settle a class-action head injury lawsuit by providing $70 million for concussion testing and diagnosis of current and former student athletes, according to court documents filed in Chicago on Tuesday. The agreement applies to student athletes who have played at NCAA member schools at any time in the past until 50 years in the future but does not include bodily injury claims. The settlement must be approved by U.S. District Judge John Lee. ...

  • The Real Danger of 'Too Much Exercise'

    The Real Danger of 'Too Much Exercise'This article was co-authored by Dr. Michael Joyner, a physiologist and anesthesiologist at the Mayo Clinic. Is too much exercise bad for you?The idea that extreme endurance exercise (e.g., exercising over an hour a day, racing multiple marathons in a lifetime, participating in Ironman distance triathlons) might be harmful for long-term heart...

  • FDA raises concerns about Impax's Taiwanese plant

    (Reuters) - Impax Laboratories Inc said the U.S. Food and Drug Administration issued certain observations regarding violations in the company's manufacturing plant in Taiwan. Shares of Impax, which makes generics and specialty drugs to treat central nervous system disorders, fell about 17 percent to $23.15 premarket on Tuesday. The FDA's investigation revealed issues including invalidated equipment used in the drug manufacturing process and a failure to reject drug products that do not conform to specifications and conduct a thorough review of failed batches. Impax said on Tuesday that the FDA did not specify the impact its observations will have on Rytary's Oct. 9 review date.

  • West African airline suspends flights amid Ebola

    LOME, Togo (AP) — The West African airline that transported a passenger sick with Ebola last week says it's now suspending flights to the two cities hardest hit by the disease.

  • The Fight for Women's Health Post-Hobby Lobby

    The Fight for Women's Health Post-Hobby LobbyWhen I joined the National Health Law Program as its new executive director, I knew to expect challenges. After all, our mission -- securing health care rights for those in need -- is a challenging one, perhaps never more so than now. The Affordable Care Act offers great hope for the tens of thousands of Americans who have been living with no...

  • Aetna to sell Obamacare exchange plans in Georgia

    (Reuters) - Aetna Chief Executive Officer Mark Bertolini said on Tuesday that the company would begin selling Obamacare exchange plans in Georgia in 2015, adding the southern state to the 17 states where it sold these plans in 2014. Bertolini said it was still too soon to tell if the new customers it gained through the exchanges in the first half of this year are more expensive than it expected, but based on what Aetna has seen, it still expects the business to be only a "modest headwind" to 2014 profits. He made the comments during a call with investors. ...

  • Merck second quarter profit tops estimates on strong consumer sales

    A view of the Merck & Co. campus in Linden, New Jersey(Reuters) - Merck & Co Inc reported better-than-expected quarterly results on Tuesday, with sales of consumer products and medicines for arthritis and HIV helping to offset the impact of generic competition on other drug sales. Merck, the No. 2 U.S. drugmaker, earned $2.03 billion, or 68 cents per share, in the second quarter. Analysts, on average, expected 81 cents, according to Thomson Reuters I/B/E/S. Global revenue slipped 1 percent to $10.93 billion, but exceeded expectations of $10.6 billion. On May 6, it agreed to sell its consumer care business to Germany’s Bayer AG for $14.2 billion, and expects to close the deal in the second half of the year.

  • 5 Office Yoga Poses (That Won't Freak Out Your Coworkers)

    5 Office Yoga Poses (That Won't Freak Out Your Coworkers)It's no surprise that sitting at a desk all day is not good for our health. So instead of feeling fidgety with discomfort, try these five yoga poses for a midday feel good stretch that will leave you tension-free and energized. Not to mention your co-workers will be able to continue their conference call, uninterrupted.1. Seated BackbendWhile...

  • Pfizer beats forecasts as oncology drugs grow

    A man walks past Pfizer's world headquarters in New York(Reuters) - Pfizer Inc , which in May officially abandoned its bid to buy British rival AstraZeneca Plc, reported higher-than-expected second-quarter revenue, helped by growing demand for its cancer medicines. Analysts on average expected 57 cents, according to Thomson Reuters I/B/E/S. Sales fell 2 percent to $12.77 billion, hurt by declines for generic medicines that Pfizer calls established products, but they exceeded Wall Street expectations of $12.46 billion.

Copyright ©  WCIB-FM. All Rights Reserved. Internet Development by Triton Digital Media.